Trials / Completed
CompletedNCT02827370
CAREFOR: Precision Medicine Driving Precision Nutrition for the Treatment of NeoAdjuvant Breast Cancer
CAREFOR Study: Precision Nutrition Caloric Restriction for Oncology Research: Precision Medicine Driving Precision Nutrition During Neoadjuvant Chemotherapy for Breast Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to determine if a targeted dietary change can enhance the effect of neo-adjuvant chemotherapy
Detailed description
Primary objective: I To determine if dietary alternations designed to downregulate the dominate molecular drivers of an individuals' breast cancer will enhance the effect of neoadjuvant chemotherapy and allow for an increase in the pathologic complete response rate. Secondary objectives I) Investigator measurable changes to molecular and patient characteristics from precision nutrition to determine a metric for evaluation this treatment in future studies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Behavioral Dietary Intervention | Receive dietary counseling |
Timeline
- Start date
- 2016-06-16
- Primary completion
- 2019-07-01
- Completion
- 2019-12-15
- First posted
- 2016-07-11
- Last updated
- 2025-04-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02827370. Inclusion in this directory is not an endorsement.